secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2024-03-05T23:59:59+00:00
Accession:  0001493152-24-008796
Event type: regulatory
Sentiment:  neutral
Materiality: 0.75
Item codes: 3.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle Pharma receives additional 180-day Nasdaq grace period through Aug 2024 for bid price compliance
--------------------------------------------------------------------------------

- Nasdaq granted additional 180-day grace period until Aug 26, 2024 to regain $1.00 minimum bid price compliance.
- Company submitted Plan of Compliance including potential reverse stock split if needed.
- Initial 180-day grace period ended Feb 27, 2024; company had not yet regained compliance.
- CEO Dr. Anatoly Dritschilo to present at Emerging Growth Conference on March 6, 2024.
- If compliance not met by Aug 26, 2024, Nasdaq will delist; appeal possible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224008796/0001493152-24-008796-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315224008796/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-008796

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer